[Expression of proto-oncogenes in human teratocarcinoma cell lines]. 1986

N N Mazurenko, and R Emanuél'-Rav'e, and F L Kiselev

UI MeSH Term Description Entries
D009857 Oncogenes Genes whose gain-of-function alterations lead to NEOPLASTIC CELL TRANSFORMATION. They include, for example, genes for activators or stimulators of CELL PROLIFERATION such as growth factors, growth factor receptors, protein kinases, signal transducers, nuclear phosphoproteins, and transcription factors. A prefix of "v-" before oncogene symbols indicates oncogenes captured and transmitted by RETROVIRUSES; the prefix "c-" before the gene symbol of an oncogene indicates it is the cellular homolog (PROTO-ONCOGENES) of a v-oncogene. Transforming Genes,Oncogene,Transforming Gene,Gene, Transforming,Genes, Transforming
D011519 Proto-Oncogenes Normal cellular genes homologous to viral oncogenes. The products of proto-oncogenes are important regulators of biological processes and appear to be involved in the events that serve to maintain the ordered procession through the cell cycle. Proto-oncogenes have names of the form c-onc. Proto-Oncogene,Proto Oncogene,Proto Oncogenes
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013724 Teratoma A true neoplasm composed of a number of different types of tissue, none of which is native to the area in which it occurs. It is composed of tissues that are derived from three germinal layers, the endoderm, mesoderm, and ectoderm. They are classified histologically as mature (benign) or immature (malignant). (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1642) Dysembryoma,Teratoid Tumor,Teratoma, Cystic,Teratoma, Mature,Teratoma, Benign,Teratoma, Immature,Teratoma, Malignant,Benign Teratoma,Benign Teratomas,Dysembryomas,Immature Teratoma,Immature Teratomas,Malignant Teratoma,Malignant Teratomas,Teratoid Tumors,Teratomas,Teratomas, Benign,Teratomas, Immature,Teratomas, Malignant,Tumor, Teratoid,Tumors, Teratoid

Related Publications

N N Mazurenko, and R Emanuél'-Rav'e, and F L Kiselev
January 1987, Doklady Akademii nauk SSSR,
N N Mazurenko, and R Emanuél'-Rav'e, and F L Kiselev
October 1990, International journal of andrology,
N N Mazurenko, and R Emanuél'-Rav'e, and F L Kiselev
January 1990, Hematological oncology,
N N Mazurenko, and R Emanuél'-Rav'e, and F L Kiselev
December 1991, Blood,
N N Mazurenko, and R Emanuél'-Rav'e, and F L Kiselev
October 1989, International journal of cancer,
N N Mazurenko, and R Emanuél'-Rav'e, and F L Kiselev
August 1988, Zhonghua Minguo wei sheng wu ji mian yi xue za zhi = Chinese journal of microbiology and immunology,
N N Mazurenko, and R Emanuél'-Rav'e, and F L Kiselev
January 1987, Urological research,
N N Mazurenko, and R Emanuél'-Rav'e, and F L Kiselev
July 1997, Hepatology (Baltimore, Md.),
N N Mazurenko, and R Emanuél'-Rav'e, and F L Kiselev
March 1991, Oral surgery, oral medicine, and oral pathology,
N N Mazurenko, and R Emanuél'-Rav'e, and F L Kiselev
October 1985, Biochemical and biophysical research communications,
Copied contents to your clipboard!